Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020Mark W Tenforde, Rebecca J Garten Kondor, Jessie R Chung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label TrialManjusha Gaglani, Sara S Kim, Allison L Naleway, et al.
Vaccine|June 16, 2022
Vaccine-associated attenuation of subjective severity among outpatients with influenzaJessie R Chung, Sara S Kim, Brendan Flannery, et al.
Open Forum Infectious Diseases|June 12, 2023
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020Allison L Naleway, Sara S Kim, Brendan Flannery, et al.
The Journal of Infectious Diseases|December 24, 2021
Vaccine Effectiveness Against Influenza Hospitalization and Emergency Department Visits in 2 A(H3N2) Dominant Influenza Seasons Among Children <18 Years Old-New Vaccine Surveillance Network 2016-2017 and 2017-2018Sara S Kim, Eric A Naioti, Natasha B Halasa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2021
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label TrialFatimah S Dawood, Allison L Naleway, Brendan Flannery, et al.
Emerging Infectious Diseases|December 23, 2024
Social Contact Patterns in Rural and Urban Settings, Mozambique, 2021-2022Moses C Kiti, Charfudin Sacoor, Obianuju G Aguolu, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
MMWR. Morbidity and Mortality Weekly Report|February 15, 2019
Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019Joshua D Doyle, Jessie R Chung, Sara S Kim, et al.
The Journal of Infectious Diseases|October 31, 2019
Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 SeasonBrendan Flannery, Rebecca J Garten Kondor, Jessie R Chung, et al.
Pageof 5